skip to Main Content
RCA In CVVHD Benefits And Limits

RCA in CVVHD Benefits and Limits

RCA in CVVHD Benefits and Limits

Prof. Detlef Kindgen-Milles will discuss some aspects of continuous renal replacement therapy in critically ill patients. The presentation will focus on anticoagulation, particularly on Regional Citrate-Anticoagulation.

Event Date: 7/17/2019
Speaker: Prof. Detlef Kindgen-Milles

Back To Top